annual CFO:
-$175.60M+$47.20M(+21.18%)Summary
- As of today (July 1, 2025), SWTX annual cash flow from operations is -$175.60 million, with the most recent change of +$47.20 million (+21.18%) on December 31, 2024.
- During the last 3 years, SWTX annual CFO has fallen by -$47.72 million (-37.32%).
- SWTX annual CFO is now -1139.58% below its all-time high of -$14.17 million, reached on December 31, 2018.
Performance
SWTX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$68.76M-$39.26M(-133.08%)Summary
- As of today (July 1, 2025), SWTX quarterly cash flow from operations is -$68.76 million, with the most recent change of -$39.26 million (-133.08%) on March 31, 2025.
- Over the past year, SWTX quarterly CFO has increased by +$10.17 million (+12.89%).
- SWTX quarterly CFO is now -556.39% below its all-time high of $15.07 million, reached on December 31, 2020.
Performance
SWTX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$165.43M+$10.17M(+5.79%)Summary
- As of today (July 1, 2025), SWTX TTM cash flow from operations is -$165.43 million, with the most recent change of +$10.17 million (+5.79%) on March 31, 2025.
- Over the past year, SWTX TTM CFO has increased by +$74.48 million (+31.04%).
- SWTX TTM CFO is now -2204.97% below its all-time high of -$7.18 million, reached on March 31, 2019.
Performance
SWTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SWTX Cash from operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +21.2% | +12.9% | +31.0% |
3 y3 years | -37.3% | -41.2% | -6.4% |
5 y5 years | -270.1% | -319.3% | -176.9% |
SWTX Cash from operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -37.3% | +21.2% | -250.7% | +12.9% | -7.7% | +31.0% |
5 y | 5-year | -445.5% | +21.2% | -556.4% | +12.9% | -413.9% | +31.0% |
alltime | all time | -1139.6% | +21.2% | -556.4% | +12.9% | -2205.0% | +31.0% |
SWTX Cash from operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$68.76M(+133.1%) | -$165.43M(-5.8%) |
Dec 2024 | -$175.60M(-21.2%) | -$29.50M(+16.2%) | -$175.60M(-15.9%) |
Sep 2024 | - | -$25.38M(-39.3%) | -$208.80M(-10.7%) |
Jun 2024 | - | -$41.79M(-47.1%) | -$233.89M(-2.5%) |
Mar 2024 | - | -$78.93M(+25.9%) | -$239.91M(+7.7%) |
Dec 2023 | -$222.79M(+37.9%) | -$62.70M(+24.3%) | -$222.79M(+4.0%) |
Sep 2023 | - | -$50.46M(+5.5%) | -$214.29M(+16.8%) |
Jun 2023 | - | -$47.81M(-22.7%) | -$183.43M(+5.0%) |
Mar 2023 | - | -$61.82M(+14.1%) | -$174.69M(+8.1%) |
Dec 2022 | -$161.56M(+26.3%) | -$54.20M(+176.5%) | -$161.56M(+5.1%) |
Sep 2022 | - | -$19.60M(-49.8%) | -$153.68M(-4.5%) |
Jun 2022 | - | -$39.07M(-19.8%) | -$161.00M(+3.6%) |
Mar 2022 | - | -$48.69M(+5.1%) | -$155.46M(+21.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$127.88M(+297.2%) | -$46.32M(+72.0%) | -$127.88M(+92.3%) |
Sep 2021 | - | -$26.93M(-19.7%) | -$66.50M(+22.5%) |
Jun 2021 | - | -$33.53M(+58.9%) | -$54.27M(+47.1%) |
Mar 2021 | - | -$21.10M(-240.1%) | -$36.90M(+14.6%) |
Dec 2020 | -$32.19M(-32.1%) | $15.07M(-202.5%) | -$32.19M(-49.2%) |
Sep 2020 | - | -$14.70M(-9.0%) | -$63.32M(+6.0%) |
Jun 2020 | - | -$16.16M(-1.5%) | -$59.73M(+5.4%) |
Mar 2020 | - | -$16.40M(+2.1%) | -$56.66M(+19.4%) |
Dec 2019 | -$47.44M(+234.9%) | -$16.06M(+44.5%) | -$47.44M(+51.2%) |
Sep 2019 | - | -$11.11M(-15.1%) | -$31.38M(+54.8%) |
Jun 2019 | - | -$13.09M(+82.4%) | -$20.27M(+182.4%) |
Mar 2019 | - | -$7.18M | -$7.18M |
Dec 2018 | -$14.17M | - | - |
FAQ
- What is SpringWorks Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics annual CFO year-on-year change?
- What is SpringWorks Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics quarterly CFO year-on-year change?
- What is SpringWorks Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics TTM CFO year-on-year change?
What is SpringWorks Therapeutics annual cash flow from operations?
The current annual CFO of SWTX is -$175.60M
What is the all time high annual CFO for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high annual cash flow from operations is -$14.17M
What is SpringWorks Therapeutics annual CFO year-on-year change?
Over the past year, SWTX annual cash flow from operations has changed by +$47.20M (+21.18%)
What is SpringWorks Therapeutics quarterly cash flow from operations?
The current quarterly CFO of SWTX is -$68.76M
What is the all time high quarterly CFO for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high quarterly cash flow from operations is $15.07M
What is SpringWorks Therapeutics quarterly CFO year-on-year change?
Over the past year, SWTX quarterly cash flow from operations has changed by +$10.17M (+12.89%)
What is SpringWorks Therapeutics TTM cash flow from operations?
The current TTM CFO of SWTX is -$165.43M
What is the all time high TTM CFO for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high TTM cash flow from operations is -$7.18M
What is SpringWorks Therapeutics TTM CFO year-on-year change?
Over the past year, SWTX TTM cash flow from operations has changed by +$74.48M (+31.04%)